Carlyle Group Inc. (CGABL) stock
CGABLNasdaqInvestment AdviceFiscal year ends December 31Also trades as CG
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 2/3060% above fair value
$14.52+0.12 (+0.83%)
Close on Nov 2, 2026Market cap $14.63BP/E 42.8Yield 3.41%
Carlyle EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Carlyle's EPS for the twelve months ending Jun 30, 2026 was $0.96, down 71.9% year over year. For fiscal 2025 it was $2.18, down 21.3% from the year before. The highest annual figure on record is $8.20 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.18 | -21.3% |
| FY2024 | Dec 31, 2024 | $2.77 | – |
| FY2023 | Dec 31, 2023 | -$1.68 | -150.1% |
| FY2022 | Dec 31, 2022 | $3.35 | -59.1% |
| FY2021 | Dec 31, 2021 | $8.20 | +745.4% |
| FY2020 | Dec 31, 2020 | $0.97 | -65.6% |
| FY2019 | Dec 31, 2019 | $2.82 | +243.9% |
| FY2018 | Dec 31, 2018 | $0.82 | -65.5% |
| FY2017 | Dec 31, 2017 | $2.38 | – |
| FY2016 | Dec 31, 2016 | -$0.08 | – |
| FY2015 | Dec 31, 2015 | -$0.30 | -124.4% |
| FY2014 | Dec 31, 2014 | $1.23 | -40.0% |
| FY2013 | Dec 31, 2013 | $2.05 | +400.0% |
| FY2012 | Dec 31, 2012 | $0.41 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.37 | -57.5% |
| Q1 FY2026 | Mar 31, 2026 | -$0.37 | -205.7% |
| Q4 FY2025 | Dec 31, 2025 | $0.96 | +68.4% |
| Q3 FY2025 | Sep 30, 2025 | $0.00 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.87 | +117.5% |
| Q1 FY2025 | Mar 31, 2025 | $0.35 | +94.4% |
| Q4 FY2024 | Dec 31, 2024 | $0.57 | – |
| Q3 FY2024 | Sep 30, 2024 | $1.63 | +640.9% |
| Q2 FY2024 | Jun 30, 2024 | $0.40 | – |
| Q1 FY2024 | Mar 31, 2024 | $0.18 | -35.7% |
| Q4 FY2023 | Dec 31, 2023 | -$1.96 | -660.0% |
| Q3 FY2023 | Sep 30, 2023 | $0.22 | -71.4% |
| Q2 FY2023 | Jun 30, 2023 | -$0.27 | -140.3% |
| Q1 FY2023 | Mar 31, 2023 | $0.28 | -82.2% |
| Q4 FY2022 | Dec 31, 2022 | $0.35 | -80.3% |
| Q3 FY2022 | Sep 30, 2022 | $0.77 | -47.3% |
| Q2 FY2022 | Jun 30, 2022 | $0.67 | -73.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.57 | -34.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.78 | +23.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.46 | +78.0% |
| Q2 FY2021 | Jun 30, 2021 | $2.55 | +522.0% |
| Q1 FY2021 | Mar 31, 2021 | $2.41 | – |
| Q4 FY2020 | Dec 31, 2020 | $1.44 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.82 | +49.1% |
| Q2 FY2020 | Jun 30, 2020 | $0.41 | -66.7% |
| Q1 FY2020 | Mar 31, 2020 | -$1.76 | -249.2% |
| Q4 FY2019 | Dec 31, 2019 | -$0.08 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.55 | +450.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.23 | +119.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.18 | +293.3% |
| Q4 FY2018 | Dec 31, 2018 | -$0.15 | -130.6% |
| Q3 FY2018 | Sep 30, 2018 | $0.10 | -76.7% |
| Q2 FY2018 | Jun 30, 2018 | $0.56 | -5.1% |
| Q1 FY2018 | Mar 31, 2018 | $0.30 | -66.7% |
| Q4 FY2017 | Dec 31, 2017 | $0.49 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.43 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.59 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.90 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.16 | – |
| Q3 FY2016 | Sep 30, 2016 | -$0.02 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics